UBS Group’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-163,904
| Closed | -$122K | – | 9489 |
|
|
2024
Q4 | $122K | Buy |
163,904
+160,912
| +5,378% | +$120K | ﹤0.01% | 5540 |
|
|
2024
Q3 | $3.65K | Buy |
2,992
+1,545
| +107% | +$1.89K | ﹤0.01% | 7028 |
|
|
2024
Q2 | $3K | Sell |
1,447
-26,263
| -95% | -$54.4K | ﹤0.01% | 7107 |
|
|
2024
Q1 | $101K | Buy |
27,710
+99
| +0.4% | +$361 | ﹤0.01% | 5065 |
|
|
2023
Q4 | $83.1K | Buy |
27,611
+14,490
| +110% | +$43.6K | ﹤0.01% | 5088 |
|
|
2023
Q3 | $28.2K | Sell |
13,121
-1,919
| -13% | -$4.13K | ﹤0.01% | 5484 |
|
|
2023
Q2 | $84.2K | Buy |
15,040
+10,986
| +271% | +$61.5K | ﹤0.01% | 5093 |
|
|
2023
Q1 | $24.4K | Buy |
4,054
+2,410
| +147% | +$14.5K | ﹤0.01% | 5845 |
|
|
2022
Q4 | $9.39K | Sell |
1,644
-1,960
| -54% | -$11.2K | ﹤0.01% | 7463 |
|
|
2022
Q3 | $20K | Buy |
+3,604
| New | +$20K | ﹤0.01% | 6327 |
|
|
2022
Q2 | – | Sell |
-297
| Closed | -$2K | – | 9871 |
|
|
2022
Q1 | $2K | Sell |
297
-1,455
| -83% | -$9.8K | ﹤0.01% | 8636 |
|
|
2021
Q4 | $20K | Buy |
1,752
+768
| +78% | +$8.77K | ﹤0.01% | 6741 |
|
|
2021
Q3 | $19K | Buy |
+984
| New | +$19K | ﹤0.01% | 6091 |
|